Cargando…
Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
BACKGROUND: Parkinson’s disease (PD) is a neurodegenerative disease characterized by selective degeneration of dopaminergic neurons in the substantia nigra (SN). The familial form of PD, PARK2, is caused by mutations in the parkin gene. parkin-knockout mouse models show some abnormalities, but they...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546866/ https://www.ncbi.nlm.nih.gov/pubmed/23039195 http://dx.doi.org/10.1186/1756-6606-5-35 |
_version_ | 1782256123393343488 |
---|---|
author | Imaizumi, Yoichi Okada, Yohei Akamatsu, Wado Koike, Masato Kuzumaki, Naoko Hayakawa, Hideki Nihira, Tomoko Kobayashi, Tetsuro Ohyama, Manabu Sato, Shigeto Takanashi, Masashi Funayama, Manabu Hirayama, Akiyoshi Soga, Tomoyoshi Hishiki, Takako Suematsu, Makoto Yagi, Takuya Ito, Daisuke Kosakai, Arifumi Hayashi, Kozo Shouji, Masanobu Nakanishi, Atsushi Suzuki, Norihiro Mizuno, Yoshikuni Mizushima, Noboru Amagai, Masayuki Uchiyama, Yasuo Mochizuki, Hideki Hattori, Nobutaka Okano, Hideyuki |
author_facet | Imaizumi, Yoichi Okada, Yohei Akamatsu, Wado Koike, Masato Kuzumaki, Naoko Hayakawa, Hideki Nihira, Tomoko Kobayashi, Tetsuro Ohyama, Manabu Sato, Shigeto Takanashi, Masashi Funayama, Manabu Hirayama, Akiyoshi Soga, Tomoyoshi Hishiki, Takako Suematsu, Makoto Yagi, Takuya Ito, Daisuke Kosakai, Arifumi Hayashi, Kozo Shouji, Masanobu Nakanishi, Atsushi Suzuki, Norihiro Mizuno, Yoshikuni Mizushima, Noboru Amagai, Masayuki Uchiyama, Yasuo Mochizuki, Hideki Hattori, Nobutaka Okano, Hideyuki |
author_sort | Imaizumi, Yoichi |
collection | PubMed |
description | BACKGROUND: Parkinson’s disease (PD) is a neurodegenerative disease characterized by selective degeneration of dopaminergic neurons in the substantia nigra (SN). The familial form of PD, PARK2, is caused by mutations in the parkin gene. parkin-knockout mouse models show some abnormalities, but they do not fully recapitulate the pathophysiology of human PARK2. RESULTS: Here, we generated induced pluripotent stem cells (iPSCs) from two PARK2 patients. PARK2 iPSC-derived neurons showed increased oxidative stress and enhanced activity of the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway. iPSC-derived neurons, but not fibroblasts or iPSCs, exhibited abnormal mitochondrial morphology and impaired mitochondrial homeostasis. Although PARK2 patients rarely exhibit Lewy body (LB) formation with an accumulation of α-synuclein, α-synuclein accumulation was observed in the postmortem brain of one of the donor patients. This accumulation was also seen in the iPSC-derived neurons in the same patient. CONCLUSIONS: Thus, pathogenic changes in the brain of a PARK2 patient were recapitulated using iPSC technology. These novel findings reveal mechanistic insights into the onset of PARK2 and identify novel targets for drug screening and potential modified therapies for PD. |
format | Online Article Text |
id | pubmed-3546866 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35468662013-01-17 Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue Imaizumi, Yoichi Okada, Yohei Akamatsu, Wado Koike, Masato Kuzumaki, Naoko Hayakawa, Hideki Nihira, Tomoko Kobayashi, Tetsuro Ohyama, Manabu Sato, Shigeto Takanashi, Masashi Funayama, Manabu Hirayama, Akiyoshi Soga, Tomoyoshi Hishiki, Takako Suematsu, Makoto Yagi, Takuya Ito, Daisuke Kosakai, Arifumi Hayashi, Kozo Shouji, Masanobu Nakanishi, Atsushi Suzuki, Norihiro Mizuno, Yoshikuni Mizushima, Noboru Amagai, Masayuki Uchiyama, Yasuo Mochizuki, Hideki Hattori, Nobutaka Okano, Hideyuki Mol Brain Research BACKGROUND: Parkinson’s disease (PD) is a neurodegenerative disease characterized by selective degeneration of dopaminergic neurons in the substantia nigra (SN). The familial form of PD, PARK2, is caused by mutations in the parkin gene. parkin-knockout mouse models show some abnormalities, but they do not fully recapitulate the pathophysiology of human PARK2. RESULTS: Here, we generated induced pluripotent stem cells (iPSCs) from two PARK2 patients. PARK2 iPSC-derived neurons showed increased oxidative stress and enhanced activity of the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway. iPSC-derived neurons, but not fibroblasts or iPSCs, exhibited abnormal mitochondrial morphology and impaired mitochondrial homeostasis. Although PARK2 patients rarely exhibit Lewy body (LB) formation with an accumulation of α-synuclein, α-synuclein accumulation was observed in the postmortem brain of one of the donor patients. This accumulation was also seen in the iPSC-derived neurons in the same patient. CONCLUSIONS: Thus, pathogenic changes in the brain of a PARK2 patient were recapitulated using iPSC technology. These novel findings reveal mechanistic insights into the onset of PARK2 and identify novel targets for drug screening and potential modified therapies for PD. BioMed Central 2012-10-06 /pmc/articles/PMC3546866/ /pubmed/23039195 http://dx.doi.org/10.1186/1756-6606-5-35 Text en Copyright ©2012 Imaizumi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Imaizumi, Yoichi Okada, Yohei Akamatsu, Wado Koike, Masato Kuzumaki, Naoko Hayakawa, Hideki Nihira, Tomoko Kobayashi, Tetsuro Ohyama, Manabu Sato, Shigeto Takanashi, Masashi Funayama, Manabu Hirayama, Akiyoshi Soga, Tomoyoshi Hishiki, Takako Suematsu, Makoto Yagi, Takuya Ito, Daisuke Kosakai, Arifumi Hayashi, Kozo Shouji, Masanobu Nakanishi, Atsushi Suzuki, Norihiro Mizuno, Yoshikuni Mizushima, Noboru Amagai, Masayuki Uchiyama, Yasuo Mochizuki, Hideki Hattori, Nobutaka Okano, Hideyuki Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue |
title | Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue |
title_full | Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue |
title_fullStr | Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue |
title_full_unstemmed | Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue |
title_short | Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue |
title_sort | mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in park2 ipsc-derived neurons and postmortem brain tissue |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546866/ https://www.ncbi.nlm.nih.gov/pubmed/23039195 http://dx.doi.org/10.1186/1756-6606-5-35 |
work_keys_str_mv | AT imaizumiyoichi mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT okadayohei mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT akamatsuwado mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT koikemasato mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT kuzumakinaoko mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT hayakawahideki mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT nihiratomoko mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT kobayashitetsuro mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT ohyamamanabu mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT satoshigeto mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT takanashimasashi mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT funayamamanabu mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT hirayamaakiyoshi mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT sogatomoyoshi mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT hishikitakako mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT suematsumakoto mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT yagitakuya mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT itodaisuke mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT kosakaiarifumi mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT hayashikozo mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT shoujimasanobu mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT nakanishiatsushi mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT suzukinorihiro mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT mizunoyoshikuni mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT mizushimanoboru mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT amagaimasayuki mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT uchiyamayasuo mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT mochizukihideki mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT hattorinobutaka mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue AT okanohideyuki mitochondrialdysfunctionassociatedwithincreasedoxidativestressandasynucleinaccumulationinpark2ipscderivedneuronsandpostmortembraintissue |